Tissue repair and recovery claims
Profiles commonly discussed for tendon, ligament, muscle, wound or recovery claims. Human evidence is kept separate from animal and laboratory findings.
Evidence pathways
Explore the Registry by research area
The A-Z is useful when you already know a compound name. This page groups evidence profiles by the research question around them, giving clearer context and shorter paths into the Registry.
Research areas
These groups are navigation aids, not recommendations. Inclusion means the compound is relevant to the topic, not that it is proven, safe or approved.
Mitochondrial and longevity biology
Compounds studied around mitochondrial signalling, cellular stress, metabolism and ageing biology, where translational evidence is often much thinner than the mechanistic story.
Metabolic and next-generation obesity research
Incretin, amylin and adjacent metabolic programmes spanning approved medicines through early pipeline candidates.
Endocrine and reproductive peptides
Established and investigational peptide medicines acting on reproductive or endocrine signalling, spanning approved therapies, clinical research and earlier evidence.
Established and reference peptide medicines
Profiles with established clinical or regulatory histories that provide useful comparison points for experimental compounds.
Bioregulators and emerging research names
Early, niche or regionally discussed compounds where evidence quality and independent replication need especially careful separation from marketing narratives.
Named blends and market aliases
These names appear in peptide-market conversation, but the marketed mixtures are not standardised medicines. Their blend profiles keep product-name claims separate from evidence for the individual ingredients.
KLOW
A marketed injectable mixture usually described as KPV, GHK-Cu, BPC-157 and TB-500 together, sold as an all-round repair and skin blend.
View blend evidence profileGLOW
A marketed injectable mixture usually described as GHK-Cu, BPC-157 and TB-500, sold on skin, hair and recovery themes.
View blend evidence profileWolverine
An informal marketed blend name typically used for BPC-157 plus TB-500, not a standardised medicinal product.
View blend evidence profileCJC-1295 + Ipamorelin
The most commonly marketed growth-hormone-axis pairing: a GHRH-type peptide combined with a ghrelin-receptor secretagogue.
View blend evidence profileMarket-name discovery helps the Registry find claims worth checking; it never upgrades an evidence rating, substitutes for primary research or points users toward sellers.
Looking for the complete Registry?
The Peptide A-Z remains the complete searchable directory with evidence-level, regulatory, category and route filters. This research-area page simply adds context and stronger paths between the main hubs and individual evidence profiles.